Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 9/18/14 → 5/28/18 |
Funding
- Pharm Olam International: $482,387.00
14-GI-91-OI (OX4218S) A Phase 2 Study to Investigate the Safety and Activity of Fosbretabulin Tromethamine (CA4P) in the Treatment of Well-Differentiated, Low-to-Intermediate-Grade Unresectable, Recurrent, or Metastatic Gastrointestinal Neuroendocrine
- Anthony, Lowell (PI)
- Myers, Adria (CoI)